Biosimilar Newsletter Archive
-
12.08.22 -- Biocon Completes Acquisition Of Viatris Biosimilar Business
12/8/2022
12/08/22 Biosimilar Development Newsletter
-
12.07.22 -- Top 2022 Articles On Process Development
12/7/2022
12/07/22 Biosimilar Development Newsletter
-
12.01.22 -- Key Insights From 2022 FDA/PDA Joint Conference
12/1/2022
12/01/22 Biosimilar Development Newsletter
-
11.23.22 -- CDMO Selection In Our Post-COVID World
11/23/2022
11/23/22 Biosimilar Development Newsletter
-
11.17.22 -- Improve And Intensify Your Upstream Processes
11/17/2022
11/17/22 Biosimilar Development Newsletter
-
11.17.22 -- A Phased Approach To Adopt In-Line Monitoring & Real-Time Release
11/17/2022
11/17/22 Biosimilar Development Newsletter
-
11.10.22 -- Pharma 4.0 Software Methodologies In Biopharma & Medical Devices
11/10/2022
11/10/22 Biosimilar Development Newsletter
-
11.07.22 -- Take Control Of Your Biomanufacturing Capacity And Timelines
11/7/2022
11/07/22 Biosimilar Development Newsletter
-
11.03.22 -- Tips For Your Virtual Meetings With The FDA
11/3/2022
11/03/22 Biosimilar Development Newsletter
-
11.02.22 -- How To De-Risk Your Biologic's Development And Manufacturing Process
11/2/2022
11/02/22 Biosimilar Development Newsletter
This website uses cookies to ensure you get the best experience on our website. Learn more